Related Experiment Video
Updated: Jun 26, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Serum Interleukin-6 as an Inflammatory Biomarker Associated with HBV Viral Load in HBsAg-Positive Chronic Hepatitis B
Jayakrishna Pamarthi1, Sugan Panneerselvam1, Nanda Amarnath Rajesh2
1Department of Microbiology, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu 603203, Tamil Nadu, India.
Insights
Interleukin-6 (IL-6) levels are closely associated with hepatitis B virus (HBV) DNA levels in patients with chronic HBV infection. This finding suggests IL-6 may be a useful biomarker for monitoring disease activity.
Area of Science:
- Hepatology
- Immunology
- Virology
Background:
- Chronic hepatitis B virus (HBV) infection is a significant global health concern.
- Interleukin-6 (IL-6) is a pro-inflammatory cytokine involved in immune responses and liver inflammation.
- The precise relationship between IL-6, HBV viral load, and disease severity requires further elucidation.
Purpose of the Study:
- To investigate the association between serum Interleukin-6 (IL-6) levels and hepatitis B virus (HBV) DNA levels in patients with chronic HBV infection.
- To explore the correlation of IL-6 with viral load and disease severity markers.
Main Methods:
- A cross-sectional study involving 293 HBsAg-positive patients.
- Serum IL-6 measured by ELISA and HBV DNA quantified by real-time PCR.
- Statistical analyses included correlation, principal component analysis (PCA), and multiple linear regression.
Main Results:
- IL-6 levels significantly increased with higher HBV DNA viral load categories (p < 0.001).
- IL-6 showed a positive correlation with HBV DNA levels (r = 0.40, p < 0.001).
- HBV DNA was identified as a significant independent predictor of IL-6 levels.
Conclusions:
- Serum IL-6 is closely associated with HBV DNA levels in chronic hepatitis B patients.
- IL-6 may serve as an adjunct biomarker for assessing disease activity in chronic HBV infection.
- The association of IL-6 with conventional liver injury markers was less pronounced than with viral load.
Background:
Chronic hepatitis B virus (HBV) infection remains a major global health challenge and a leading cause of liver cirrhosis and hepatocellular carcinoma. Interleukin-6 (IL-6), a key pro-inflammatory cytokine, plays an important role in immune regulation and hepatic inflammation. However, its relationship with HBV viral load and disease severity remains incompletely understood.
Methods:
A hospital-based cross-sectional study was conducted among 293 HBsAg-positive patients. Serum IL-6 levels were measured using ELISA, and HBV DNA was quantified using real-time quantitative PCR. Patients were stratified according to viral load. Statistical analyses included non-parametric tests, Spearman correlation, principal component analysis (PCA), and multiple linear regression.
Results:
The median age was 45 years (IQR: 34-57), among which 54.6% were male. The median HBV DNA was 3.37 log10 IU/mL (IQR: 2.45-3.75), and IL-6 concentration was 2.38 log10 pg/mL (IQR: 2.21-2.49). IL-6 levels increased significantly across viral load categories (p < 0.001) and were higher in HBeAg-positive patients (p = 0.002), with no significant differences across age, sex, or cirrhosis. IL-6 levels correlated with HBV DNA (r = 0.40, p < 0.001). PCA identified distinct viral-inflammatory and biochemical axes. Regression analysis confirmed HBV DNA as the significant independent predictor (β = 0.461, p < 0.001; adjusted R2 = 0.206).
Conclusion:
IL-6 was closely associated with HBV DNA levels, while the association with conventional biochemical markers of hepatocellular injury was significantly less in this cohort, suggesting that IL-6 may serve as an adjunct biomarker of disease activity in patients with chronic hepatitis B.
More Related Videos
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis

